Meeting
2020 ASCO Virtual Scientific Program
Percutaneous hepatic injection of rose bengal disodium (PV-10) in metastatic uveal melanoma.
Authors
Sapna Pradyuman Patel
The University of Texas MD Anderson Cancer Center, Houston, TX
Sapna Pradyuman Patel , Brett W. Carter , Ravi Murthy , Rahul Sheth , Sanjiv S. Agarwala , Gary Lu , Ellen Redstone , Gener C Balmes , Helene Rider , Dominic Rodrigues , Eric Andrew Wachter
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics—Immunotherapy
Sub Track
Other IO-Related Topics
Clinical Trial Registration Number
NCT00986661
Citation
J Clin Oncol 38: 2020 (suppl; abstr 3143)
DOI
10.1200/JCO.2020.38.15_suppl.3143
Abstract #
3143
Poster Bd #
207
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Avelumab (MSB0010718C; anti-PD-L1) in patients with metastatic urothelial carcinoma from the JAVELIN solid tumor phase 1b trial: Analysis of safety, clinical activity, and PD-L1 expression.
First Author: Andrea B. Apolo
Poster
2024 ASCO Annual Meeting
Ipatasertib in patients with AKT1/2/3 mutation-positive (AKTmut) tumors: TAPISTRY study.
First Author: David Morgan Thomas
Poster
2023 ASCO Annual Meeting
Subgroup analyses of safety and efficacy by number and types of prior lines of treatment in FRESCO-2, a global phase III study of fruquintinib in patients with refractory metastatic colorectal cancer.
First Author: Arvind Dasari
Poster
2023 ASCO Annual Meeting
Pelabresib (CPI-0610) monotherapy in high-risk essential thrombocythemia refractory or intolerant to hydroxyurea: Preliminary results from MANIFEST study.
First Author: Francesco Passamonti